Skip to main content
. 2021 Jul 5;2021(7):CD011301. doi: 10.1002/14651858.CD011301.pub2

63.1. Analysis.

63.1

Comparison 63: NewBontA (Prosigne®) 20 units versus OnabotulinumtoxinA 20 units one treatment in glabellar lines, Outcome 1: Physician assessment of success by analysing scores and scales